Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30239% above fair value
$4.54−0.12 (-2.58%)
Close on Nov 13, 2026Market cap $1.63BP/E 113.5Yield –
Precigen statistics
93 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Mar 24, 2027 (estimated, during market hours)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 13, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 24.50
- 2.22
Enterprise valuationIndustry
- EV / Sales
- 10.63
- 2.57
- EV / EBIT
- 49.62
- 19.31
Share statisticsIndustry
- Shares Change (YoY)
- 29.6%
- 10.8%
- Shares Change (QoQ)
- 0.15%
- 0.50%
- Float
- 197M
- 49M
- Shares Held by Insiders
- 44.9%
- 11.7%
- Shares Held by Institutions
- 39.2%
- 56.4%
Short sellingIndustry
- Short Interest
- 45M
- –
- Short Interest Change
- -3.19%
- -0.80%
- Short % of Float
- 22.8%
- 9.01%
- Short % of Shares Outstanding
- 12.5%
- 6.30%
- Days to Cover
- 8.56
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $8.98
- –
- 52-Week Low
- $3.04
- –
- 20-Day Moving Average
- $5.59
- –
- 50-Day Moving Average
- $6.74
- –
- 200-Day Moving Average
- $5.28
- –
- Average True Range (14)
- $0.50
- –
- Price Change (1 Week)
- 1.57%
- -1.15%
- Price Change (1 Month)
- -36.9%
- -4.87%
- Price Change (3 Months)
- -30.7%
- -21.0%
- Price Change (6 Months)
- 2.71%
- -20.6%
- Price Change (YTD)
- 8.61%
- -23.6%
- Price Change (1 Year)
- 12.9%
- -22.4%
- Price Change (3 Years)
- 349.5%
- -29.5%
- Price Change (5 Years)
- 4.85%
- -77.9%
- Price Change (10 Years)
- -85.8%
- -65.4%
- Average Volume (10 Days)
- 11M
- –
- Average Volume (20 Days)
- 8M
- –
- Average Volume (90 Days)
- 6M
- –
- Relative Volume
- 0.68
- 0.70
- Relative Strength Index (14)
- 34.2
- 43.4
- Volatility (1 Year)
- 85.4%
- 80.1%
- Beta (5 Years)
- 1.63
- 1.07
MarginsIndustry
- Pretax Margin
- 15.7%
- -11.6%
- EBITDA Margin
- 24.3%
- -27.7%
- FCF Margin
- -47.4%
- -9.56%
Returns on capitalIndustry
- Return on Equity (ROE)
- 38.8%
- -49.9%
- Return on Assets (ROA)
- 12.7%
- -40.6%
- Return on Invested Capital (ROIC)
- 147.3%
- -32.9%
- Return on Capital Employed (ROCE)
- 18.5%
- -37.9%
Financial positionIndustry
- Current Ratio
- 5.58
- 3.30
- Quick Ratio
- 4.79
- 2.39
- Debt / Equity
- 1.12
- 0.49
- Debt / EBITDA
- 2.48
- 3.15
- Net Debt / EBITDA
- 1.14
- 1.97
- Interest Coverage
- 2.85
- -6.35
GrowthIndustry
- Revenue Growth (3Y CAGR)
- -28.9%
- 2.25%
- Revenue Growth (5Y CAGR)
- -21.3%
- 6.41%
EfficiencyIndustry
- Asset Turnover
- 0.82
- 0.40
- Revenue Per Employee
- $7.85M
- $429.29K
- Profits Per Employee
- $1.22M
- -$689.41K
- Employee Count
- 20
- 74
- WACC
- 13.2%
- 10.2%
Income statement (TTM)Industry
- Pretax Income
- $24.61M
- -$12.95M
Balance sheetIndustry
- Net Cash (Debt)
- -$43.28M
- $17.76M
- Net Cash Per Share
- -$0.12
- $0.80
- Equity (Book Value)
- $83.79M
- $53.89M
- Book Value Per Share
- $0.23
- $1.50
- Tangible Book Value
- $66.34M
- $27.13M
- Working Capital
- $140.97M
- $79.99M
Cash flow (TTM)Industry
- Capital Expenditures
- -$1.10M
- -$1.00M
- FCF Per Share
- -$0.21
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 1.50%
- -21.8%
- FCF Yield
- -4.57%
- -9.44%
- Buyback Yield
- 0.00%
- -0.76%
- Shareholder Yield
- 0.00%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $11.82M
- $2.90M
- Income Tax
- $200.00K
- $73.00K
- Effective Tax Rate
- 0.81%
- 20.9%
Scores and fair valueIndustry
- Graham Number
- $0.46
- $19.34
- Graham Upside
- -89.9%
- -46.6%
- Altman Z-Score
- -5.48
- 0.23
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | PGEN | S&P 500 | Difference | PGEN per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -39.3% | -3.0% | −36.3 pts | ||
| 3 months | -30.0% | -2.8% | −27.3 pts | ||
| Year to date | +8.6% | +11.5% | −2.9 pts | ||
| 1 year | +17.6% | +13.5% | +4.2 pts | ||
| 3 years | +410.1% | +77.7% | +332.4 pts | +72.1% | +21.1% |
| 5 years | +4.8% | +72.6% | −67.8 pts | +1.0% | +11.5% |
| 10 years | -84.7% | +308.2% | −392.9 pts | -17.1% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
45M PGEN shares were sold short on Oct 30, 2026, down 3.2% from the previous report, or 22.77% of the shares available to trade. At recent volumes it would take 8.6 days to buy them back. Over the last 20 sessions, 49.4% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 44,908,434 | -3.2% | 5,245,464 | 8.6 |
| Oct 15, 2026 | 46,390,144 | -2.4% | 4,542,276 | 10.2 |
| Sep 30, 2026 | 47,547,517 | +12.5% | 6,444,570 | 7.4 |
| Sep 15, 2026 | 42,278,237 | +0.2% | 2,598,893 | 16.3 |
| Aug 31, 2026 | 42,180,337 | -0.1% | 5,332,363 | 7.9 |
| Aug 14, 2026 | 42,240,157 | +0.5% | 7,214,381 | 5.8 |
| Jul 31, 2026 | 42,044,362 | +2.5% | 3,779,683 | 11.1 |
| Jul 15, 2026 | 41,025,860 | -7.2% | 4,263,642 | 9.6 |
| Jun 30, 2026 | 44,222,506 | +2.0% | 5,810,243 | 7.6 |
| Jun 15, 2026 | 43,338,122 | +7.7% | 5,866,310 | 7.4 |
| May 29, 2026 | 40,254,841 | +1.0% | 4,211,529 | 9.6 |
| May 15, 2026 | 39,871,277 | +0.3% | 3,607,150 | 11.1 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?